Our Team
At Biorizon Consulting, our team is made up of highly skilled international professionals with diverse backgrounds in life science, pharmacology, public health, GxP and finance all dedicated to shaping the preclinical landscape.
We bring extensive experience to the table, having navigated complex strategic challenges and managed demanding projects. Each of us contributes a unique perspective and deep expertise, working together to provide tailored, innovative solutions that meet the highest standards for our clients.
Dr. Laura-Marie Zimmermann
Founder and Director
Laura is a passionate advocate for innovation within the life sciences, with a particular focus on fostering preclinical trial research, where she believes the next breakthroughs will emerge. She is an experienced expert in preclinical trial design, with a strong background in growth factors, medical devices, cardiovascular and rare disease research and MedTech. Laura supports clients through the complexities of early-stage innovation, collaborating with global industry leader.
As the founding partner and director of Biorizon Consulting, Laura guides the firm’s direction by integrating European and Asia-Pacific insights, nurturing top consulting talent, and driving strategic decisions in drug development and innovation. Her additional role as a Preclinical Board Advisor further strengthens her commitment to excellence and her influence within the field.
Laura’s background includes roles as a scientific researcher at the University Hospital Cologne and the Max-Planck Institute in Germany. She holds a PhD in Biochemistry from the University of Cologne and M.Sc. and B.Sc. degrees in Chemical Biology from the Technical University Dortmund, Germany.
-
Nigel Cryer
SENIOR ASSOCIATE CONSULTANT
GxP Compliance Expert, Managing Director Bluciela-Lifesciences SASNigel, Managing Director of Bluciela-Lifesciences SAS, brings over 30 years of experience in pharmaceutical industries. He specialises in FDA readiness, GxP compliance, logistics, data integrity, and operational excellence.
Renowned for his expertise in navigating complex regulatory environments and developing effective strategies, Nigel excels in managing successful inspection preparations and driving operational improvements.
His deep industry knowledge and extensive network support his ability to deliver innovative solutions and enhance efficiency.
-
Prof. Ricardo Hermosilla
SENIOR ASSOCIATE CONSULTANT
Pharmaceutical Drug Development and Rare Disease Expert
Ricardo is a seasoned expert with over 12 years of experience in Translational Medicine, Clinical Pharmacology, and Clinical Development, particularly in the area of Rare Diseases. With a robust academic background spanning more than 15 years in Human and Veterinary Pharmacology, his leadership in preclinical trial development and study design is invaluable to Biorizon Consulting.
Ricardo's deep expertise in molecular pharmacology and his strategic approach to clinical development drive innovative solutions that strengthen our ability to support clients in the life sciences sector.
-
Andrew Sutherland
SENIOR ASSOCIATE CONSULTANT
Technology and Finance ExpertAndrew is a seasoned technology and finance expert with experience in both multinational corporations and startups. His roles at Infosys Consulting and Booking.com provided him with deep expertise in corporate finance, product management, and digital technologies, including API development and Machine Learning. With a degree in Biological Sciences and an MBA from Imperial College London, Andrew seamlessly blends scientific knowledge with business acumen.
Andrew’s financial and business expertise is essential for early drug development, driving budget optimisation, risk assessment, financial modeling, and strategic planning.
-
Jennifer Buck
SENIOR ASSOCIATE CONSULTANT
Public Health Nutrition Expert
Jenny is a seasoned Public Health Nutrition researcher with over 10 years of experience, holding an MSc from the London School of Hygiene and Tropical Medicine and a BSc from Loughborough University. She has carried out WHO-funded research on chronic disease prevention and management, including a systematic review and meta-analyses on mobile technology. Jenny's expertise spans quantitative research, and scientific communication with multiple high-quality publications. Her contributions also include book chapter on climate change and health. Jenny’s dedication to public health and her strong communication skills make her a valuable asset in life science consulting.